|
Citi is having a conf call today on MM. It says its about to issue two CELG reports diving deep into the great MM015 trial and laying out in detail the Revlimid opportunity WORLDWIDE.
In multiple biotech reports the past week or so on OTHER biotech companies - Citi has repeated that CELG is its top pick right now. Rating :
 (No ratings) |
40/Male |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
0.74